These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37481435)

  • 41. Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.
    Bellomo R; Forni LG; Busse LW; McCurdy MT; Ham KR; Boldt DW; Hästbacka J; Khanna AK; Albertson TE; Tumlin J; Storey K; Handisides D; Tidmarsh GF; Chawla LS; Ostermann M
    Am J Respir Crit Care Med; 2020 Nov; 202(9):1253-1261. PubMed ID: 32609011
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure.
    Kinugawa T; Ogino K; Kitamura H; Saitoh M; Omodani H; Osaki S; Hisatome I; Miyakoda H
    Am J Med Sci; 1996 Sep; 312(3):110-7. PubMed ID: 8783676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
    Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G
    Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensin II blockade during combined thiazide-beta-blocker treatment.
    Ibsen H; Leth A; McNair A; Christensen NJ; Giese J
    Scand J Clin Lab Invest; 1980 Jun; 40(4):325-31. PubMed ID: 6106282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alteration of the Renin-Angiotensin-Aldosterone System in Shock: Role of the Dipeptidyl Peptidase 3.
    Picod A; Deniau B; Vaittinada Ayar P; Genest M; Julian N; Azibani F; Mebazaa A
    Am J Respir Crit Care Med; 2021 Feb; 203(4):526-527. PubMed ID: 33152252
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
    Brown NJ; Agirbasli M; Vaughan DE
    Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Renin-Angiotensin-Aldosterone System Dysfunction With Angiotensin II in High-Renin Septic Shock.
    Chow JH; Wallis M; Lankford AS; Chancer Z; Barth RN; Scalea JR; LaMattina JC; Mazzeffi MA; McCurdy MT
    Semin Cardiothorac Vasc Anesth; 2021 Mar; 25(1):67-73. PubMed ID: 32787515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renin Levels and Angiotensin II Responsiveness in Vasopressor-Dependent Hypotension.
    See EJ; Chaba A; Spano S; Maeda A; Clapham C; Burrell LM; Liu J; Khasin M; Liskaser G; Eastwood G; Bellomo R
    Crit Care Med; 2024 Aug; 52(8):1218-1227. PubMed ID: 38511994
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between aldosterone and bradykinin.
    Mersey JH; Williams GH; Hollenberg NK; Dluhy RG
    Circ Res; 1977 May; 40(5 Suppl 1):I84-8. PubMed ID: 870233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Responses of plasma bradykinin and the renin angiotensin axis to angiotensin II in hyperthyroid patients].
    Takeda Y; Miyamori I; Ikeda M; Koshida H; Yasuhara S; Morise T; Okamoto S; Kawato M; Takeda R
    Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):61-8. PubMed ID: 3009241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study.
    Klijian A; Khanna AK; Reddy VS; Friedman B; Ortoleva J; Evans AS; Panwar R; Kroll S; Greenfeld CR; Chatterjee S
    J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):51-58. PubMed ID: 32868152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of bariatric surgery on cardiac structure and function in obese patients: Role of the renin-angiotensin system.
    Oliveras A; Molina L; Goday A; Sans L; Riera M; Vazquez S; Benaiges D; Granados AM; Ramon JM; Pascual J
    J Clin Hypertens (Greenwich); 2021 Jan; 23(1):181-192. PubMed ID: 33331692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
    Arroyo V; Bosch J; Mauri M; Ribera F; Navarro-López F; Rodés J
    Eur J Clin Invest; 1981 Jun; 11(3):221-9. PubMed ID: 6791942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of angiotensin III on blood pressure, renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Suzuki S; Doi Y; Aoi W; Kuramochi M; Hashiba K
    Jpn Heart J; 1984 Jan; 25(1):75-85. PubMed ID: 6376863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reply to Picod
    Chawla LS; Bellomo R
    Am J Respir Crit Care Med; 2021 Feb; 203(4):527-528. PubMed ID: 33152253
    [No Abstract]   [Full Text] [Related]  

  • 57. Identifying a disease-specific renin-angiotensin-aldosterone system fingerprint in patients with primary adrenal insufficiency.
    Wolf P; Mayr J; Beiglböck H; Fellinger P; Winhofer Y; Poglitsch M; Gessl A; Kautzky-Willer A; Luger A; Krebs M
    Eur J Endocrinol; 2019 Jul; 181(1):39-44. PubMed ID: 31075757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of the renin-angiotensin-aldosterone and kallikrein-kinin systems in the control of fluid and electrolyte metabolism, renal function, and arterial blood pressure.
    McCaa RE
    Clin Exp Hypertens A; 1982; 4(9-10):1593-611. PubMed ID: 6754146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
    Stephan D; Grima M; Welsch M; Barthelmebs M; Vasmant D; Imbs J
    Fundam Clin Pharmacol; 1996; 10(5):474-83. PubMed ID: 8902551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of des-Asp1-angiotensin II on blood pressure, plasma aldosterone concentration, and plasma renin activity in the rabbit.
    Steele JM; Neusy AJ; Lowenstein J
    Circ Res; 1976 Jun; 38(6 Suppl 2):113-6. PubMed ID: 178463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.